Brainlab HybridArc software for radiosurgery gains US clearance

19 May 2011

Brainlab has received 510(k) clearance from the FDA for its HybridArc radiosurgery planning solution.

The software increases the efficiency of existing Linac (linear accelerator) radiosurgery hardware and offers fast, high precision volumetric arc radiosurgery treatment without the need for costly hardware upgrades.

HybridArc expands upon the clinically proven and well established Dynamic Arc stereotactic treatment technique to offer high dose conformity to the target, while sparing nearby organs and offering less residual dose when compared to other techniques such as rotational Intensity Modulated Radiotherapy.

 HybridArc uses an adaptive dose calculation matrix that takes into account the different parameters affecting dose distribution to provide the necessary precision when opting for stereotactic radiosurgery.

By using software automation, HybridArc calculates plans typically within a few minutes. Coupled with reduced treatment times, more patients can potentially benefit from advanced radiosurgery. From planning through to patient treatment, HybridArc ensures clinicians can meet the demands of high dose single fraction radiosurgery.

Thierry Gevaert, Medical Physicist at Universitair Ziekenhuis, Brussels, Belgium, who will be using the new system at his radiosurgery centre comments: “We have looked at HybridArc as a cost-effective way to expand and improve on the capabilities offered by our current radiosurgery system. By using HybridArc we can get the most from our treatment machine, and treat more patients with precision and speed without having to invest in an expensive new system.”